4th Quarter - Report

TIBER CREEK GROUP for PHRMA

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

H.R. 1260, Patent Reform Act of 2009.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ CoS, Representative Bean

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th)

Trade (domestic/foreign) TRD

Intellectual property protection issues.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ CoS, Representative Bean

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

H.R. 3200, America's Affordable Health Choices Act of 2009. S. 1796, Americas Healthy Future Act of 2009. S. 1679, Affordable Health Choices Act. Dorgan Amendment # 2793 to the Patient Protection and Affordable Care Act. Medicaid Drug Rebates. Reforms to Medicare Part D. S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009. H.R. 1548, Pathway for Biologics Act. H.R. 2502, Comparative Effectiveness Research Act of 2009. Changes to the 340b program.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ CoS, Representative Bean
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1796 (111th), H.R. 2502 (111th), S. 1679 (111th), H.R. 3200 (111th), H.R. 1548 (111th), S. 525 (111th)

Medicare/Medicaid MMM

H.R. 3200, America's Affordable Health Choices Act of 2009. S. 1796, Americas Healthy Future Act of 2009. S. 1679, Affordable Health Choices Act. Medicaid Drug Rebates. Reforms to Medicare Part D.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ CoS, Representative Bean
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1679 (111th), H.R. 3200 (111th), S. 1796 (111th)

Pharmacy PHA

S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009. Dorgan Amendment # 2793 to the Patient Protection and Affordable Care Act. Support for H.R. 1548, Pathway for Biologics Act. H.R. 2502, Comparative Effectiveness Research Act of 2009. Changes to the 340b program.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ CoS, Representative Bean
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 525 (111th), H.R. 1548 (111th), H.R. 2502 (111th)

Medical/Disease Research/Clinical Labs MED

H.R. 3200, America's Affordable Health Choices Act of 2009. S. 1796, Americas Healthy Future Act of 2009. S. 1679, Affordable Health Choices Act. Support for H.R. 1548, Pathway for Biologics Act. H.R. 2502, Comparative Effectiveness Research Act of 2009. Changes to the 340b program.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ CoS, Representative Bean
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2502 (111th), S. 1796 (111th), S. 1679 (111th), H.R. 3200 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.